Pages that link to "Q91204390"
Jump to navigation
Jump to search
The following pages link to Susanne Keiding (Q91204390):
Displaying 50 items.
- Capillaries within compartments: microvascular interpretation of dynamic positron emission tomography data (Q30882247) (← links)
- Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy (Q33322024) (← links)
- Benefits and risks of transforming data from dynamic positron emission tomography, with an application to hepatic encephalopathy (Q33387748) (← links)
- Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy (Q33388077) (← links)
- The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study (Q33476505) (← links)
- Transjugular Intrahepatic Portosystemic Shunt Does Not Alter Cerebral Blood Flow (Q33977795) (← links)
- Impairment of the organization of locomotor and exploratory behaviors in bile duct-ligated rats (Q34269099) (← links)
- Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [(11)C]acetate in humans (Q34441809) (← links)
- Tracer input for kinetic modelling of liver physiology determined without sampling portal venous blood in pigs (Q34494566) (← links)
- Hepatic ethanol elimination kinetics in patients with cirrhosis. (Q34802765) (← links)
- Hepatic blood perfusion measured by 3-minute dynamic 18F-FDG PET in pigs (Q35085924) (← links)
- Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-D-galactose from Talose triflate and biodistribution in a porcine model. (Q35090198) (← links)
- The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma. (Q35154056) (← links)
- Analogue tracers and lumped constant in capillary beds (Q35184425) (← links)
- PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer. (Q35653992) (← links)
- Budd-Chiari and inferior caval vein syndromes due to membranous obstruction of the liver veins: successful treatment with angioplasty and transcaval transjugular intrahepatic porto-systemic shunt (Q35932412) (← links)
- [N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs (Q36079634) (← links)
- Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT (Q36125251) (← links)
- Hepatic blood perfusion estimated by dynamic contrast-enhanced computed tomography in pigs: limitations of the slope method (Q36218385) (← links)
- Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography (Q36807780) (← links)
- Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT (Q36864209) (← links)
- New findings on cerebral ammonia uptake in HE using functional (13)N-ammonia PET. (Q36935390) (← links)
- Brain alanine formation as an ammonia-scavenging pathway during hyperammonemia: effects of glutamine synthetase inhibition in rats and astrocyte-neuron co-cultures (Q37073404) (← links)
- A method to estimate dispersion in sampling catheters and to calculate dispersion-free blood time-activity curves (Q37170380) (← links)
- Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats (Q37627757) (← links)
- Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy. (Q38078273) (← links)
- Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT-reproducibility and clinical potential. (Q38602602) (← links)
- Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma (Q39673718) (← links)
- Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts. (Q39893186) (← links)
- Human (13)N-ammonia PET studies: the importance of measuring (13)N-ammonia metabolites in blood (Q39924582) (← links)
- Hepatobiliary Secretion Kinetics of Conjugated Bile Acids Measured in Pigs by 11C-Cholylsarcosine PET. (Q39929962) (← links)
- Hepatic metabolism of 11C-methionine and secretion of 11C-protein measured by PET in pigs (Q41180678) (← links)
- No oxygen delivery limitation in hepatic encephalopathy (Q42467797) (← links)
- Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode (Q42910923) (← links)
- The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease (Q43894518) (← links)
- Quantification of (18)F-FDG uptake in the liver using dynamic PET. (Q43909551) (← links)
- Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma (Q44050029) (← links)
- Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing (Q44114209) (← links)
- Impulse-response function of splanchnic circulation with model-independent constraints: theory and experimental validation (Q44397843) (← links)
- Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake. (Q44479204) (← links)
- Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours (Q44514473) (← links)
- 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer (Q45180613) (← links)
- Hepatic microcirculation assessed by positron emission tomography of first-pass ammonia metabolism in porcine liver (Q45255389) (← links)
- Forearm and leg amino acid metabolism in the basal state and during combined insulin and amino acid stimulation after a 3-day fast. (Q45976647) (← links)
- Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia (Q46090266) (← links)
- Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. (Q46208069) (← links)
- Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors (Q46528573) (← links)
- Impairment of short term memory in rats with hepatic encephalopathy due to bile duct ligation. (Q46678001) (← links)
- Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography (Q46865816) (← links)
- Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. (Q46893493) (← links)